Literature DB >> 17430988

Brief hyperglycaemia in the early pregnant rat increases fetal weight at term by stimulating placental growth and affecting placental nutrient transport.

Anette Ericsson1, Karin Säljö, Eleonor Sjöstrand, Nina Jansson, Puttur D Prasad, Theresa L Powell, Thomas Jansson.   

Abstract

In pregnant women with type 1 diabetes, suboptimal glucose control in the first trimester is a strong predictor for giving birth to a large fetus. However, the mechanisms underlying this association are unknown. We hypothesized that transient hyperglycaemia in early pregnancy results in (1) increased placental growth and (2) an up-regulation of placental nutrient transport capacity, which leads to fetal overgrowth at term. In order to test this hypothesis, pregnant rats were given intraperitoneal injections of glucose (2 g kg(-1), resulting in a 50-100% increase in blood glucose level during 90 min) or saline (control) in either early or late gestation using four different protocols: one single injection on gestational day (GD) 10 (n=5), three injections on GD 10 (n=8-9), six injections on GD 10 and 11 (n=9-11) or three injections on GD 19 (n=7-8). Multiple injections were given approximately 4 h apart. Subsequently, animals were studied on GD 21. Three glucose injections in early pregnancy significantly increased placental weight by 10%, whereas fetal weight was found to be increased at term in response to both three (9% increase in fetal weight, P<0.05) and six glucose injections (7%, P=0.05) in early gestation. A single glucose injection on GD 10 or three injections of glucose on GD 19 had no effect on placental or fetal growth. In groups where a change in feto-placental growth was observed, we measured placental system A and glucose transport activity in the awake animals on GD 21 and placental expression of the glucose and amino acid transporters GLUT1, GLUT3, SNAT2 (system A), LAT1 and LAT 2 (system L). Placental system A transport at term was down-regulated by six glucose injections in early pregnancy (by -33%, P<0.05), whereas placental mRNA and protein levels were unchanged. No long-term alterations in maternal metabolic status were detected. In conclusion, we demonstrate that transient hyperglycaemia in early pregnancy is sufficient to increase fetal weight close to term. In contrast, brief hyperglycaemia in late pregnancy did not stimulate fetal growth. Increased fetal growth may be explained by a larger placenta, which would allow for more nutrients to be transferred to the fetus. These data suggest that maternal metabolic control in early pregnancy is an important determinant for feto-placental growth and placental function throughout the remainder of gestation. We speculate that maternal metabolism in early pregnancy represents a key environmental cue to which the placenta responds in order to match fetal growth rate with the available resources of the mother.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17430988      PMCID: PMC2170823          DOI: 10.1113/jphysiol.2007.131185

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  32 in total

1.  Calpastatin is up-regulated in response to hypoxia and is a suicide substrate to calpain after neonatal cerebral hypoxia-ischemia.

Authors:  K Blomgren; U Hallin; A L Andersson; M Puka-Sundvall; B A Bahr; A McRae; T C Saido; S Kawashima; H Hagberg
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

2.  Effect of low-level basal plus marked "pulsatile" hyperglycemia on insulin secretion in fetal sheep.

Authors:  T D Carver; S M Anderson; P W Aldoretta; W W Hay
Journal:  Am J Physiol       Date:  1996-11

3.  Modification of the Laemmli sodium dodecyl sulfate-polyacrylamide gel electrophoresis procedure to eliminate artifacts on reducing and nonreducing gels.

Authors:  S Cannon-Carlson; J Tang
Journal:  Anal Biochem       Date:  1997-03-01       Impact factor: 3.365

4.  Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population.

Authors:  B M Casey; M J Lucas; D D Mcintire; K J Leveno
Journal:  Obstet Gynecol       Date:  1997-12       Impact factor: 7.661

5.  Diabetes alters the expression and activity of the human placental GLUT1 glucose transporter.

Authors:  K Gaither; A N Quraishi; N P Illsley
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

6.  Fetal size at birth in relation to quality of blood glucose control in pregnancies complicated by pregestational diabetes mellitus.

Authors:  B Persson; U Hanson
Journal:  Br J Obstet Gynaecol       Date:  1996-05

7.  Placental transport of leucine and lysine is reduced in intrauterine growth restriction.

Authors:  T Jansson; V Scholtbach; T L Powell
Journal:  Pediatr Res       Date:  1998-10       Impact factor: 3.756

8.  Diabetes and obesity in the offspring of Pima Indian women with diabetes during pregnancy.

Authors:  D J Pettitt; R G Nelson; M F Saad; P H Bennett; W C Knowler
Journal:  Diabetes Care       Date:  1993-01       Impact factor: 19.112

9.  Abnormal glucose tolerance during pregnancy in Pima Indian women. Long-term effects on offspring.

Authors:  D J Pettitt; P H Bennett; M F Saad; M A Charles; R G Nelson; W C Knowler
Journal:  Diabetes       Date:  1991-12       Impact factor: 9.461

10.  Placental glucose transport and GLUT 1 expression in insulin-dependent diabetes.

Authors:  T Jansson; M Wennergren; T L Powell
Journal:  Am J Obstet Gynecol       Date:  1999-01       Impact factor: 8.661

View more
  27 in total

1.  Placental growth response to maternal insulin in early pregnancy.

Authors:  Perrie O'Tierney-Ginn; Larraine Presley; Stephen Myers; Patrick Catalano
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

2.  Effects of twin pregnancy and periconceptional undernutrition on maternal metabolism, fetal growth and glucose-insulin axis function in ovine pregnancy.

Authors:  C W H Rumball; J E Harding; M H Oliver; F H Bloomfield
Journal:  J Physiol       Date:  2008-01-10       Impact factor: 5.182

Review 3.  Understanding placental nutrient transfer--why bother? New biomarkers of fetal growth.

Authors:  C P Sibley
Journal:  J Physiol       Date:  2009-05-05       Impact factor: 5.182

Review 4.  Nutritional programming of disease: unravelling the mechanism.

Authors:  Simon C Langley-Evans
Journal:  J Anat       Date:  2008-10-14       Impact factor: 2.610

Review 5.  Vascular dysfunction in the diabetic placenta: causes and consequences.

Authors:  Lopa Leach; Alice Taylor; Flavia Sciota
Journal:  J Anat       Date:  2009-07       Impact factor: 2.610

6.  Gestational Timing of Prenatal Disturbance and Fetal Sex Determine the Developmental Outcomes.

Authors:  Danielle N Rendina; Gabriele R Lubach; Christopher L Coe
Journal:  Neonatology       Date:  2016-02-24       Impact factor: 4.035

7.  Identification of maternally regulated fetal gene networks in the placenta with a novel embryo transfer system in mice.

Authors:  Paranthaman SenthamaraiKannan; Maureen A Sartor; Kyle T O'Connor; Jonathan C Neumann; James P Klyza; Paul A Succop; Brad D Wagner; Saikumar Karyala; Mario Medvedovic; Anil G Menon
Journal:  Physiol Genomics       Date:  2011-01-04       Impact factor: 3.107

8.  Cadmium associated with inhaled cadmium oxide nanoparticles impacts fetal and neonatal development and growth.

Authors:  Jason L Blum; Judy Q Xiong; Carol Hoffman; Judith T Zelikoff
Journal:  Toxicol Sci       Date:  2012-01-12       Impact factor: 4.849

9.  Fructose intake during pregnancy up-regulates the expression of maternal and fetal hepatic sterol regulatory element-binding protein-1c in rats.

Authors:  Yuuka Mukai; Maya Kumazawa; Shin Sato
Journal:  Endocrine       Date:  2012-10-13       Impact factor: 3.633

10.  Nitric oxide synthase activity and expression are decreased in the paraventricular nucleus of pregnant rats.

Authors:  Cheryl M Heesch; Hong Zheng; C Michael Foley; Patrick J Mueller; Eileen M Hasser; Kaushik P Patel
Journal:  Brain Res       Date:  2008-11-19       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.